FMS-Like Tyrosine Kinase 3 Inhibitors in the Treatment of Acute Myeloid Leukemia: An Update on the Emerging Evidence and Safety Profile
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - January 18, 2023 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
A Refractory Case of CDKN2A/B Loss Metastatic Intrahepatic Cholangiocarcinoma Achieving a Partial Response After First-Line Treatment with Palbociclib
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - January 18, 2023 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
A Primary Lung and Breast Cancer Patient with Germline EGFR R776H Mutation: A Case Report and Literature Review
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - January 17, 2023 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Post-Hematopoietic Cell Transplantation Relapsed Acute Lymphoblastic Leukemia: Current Challenges and Future Directions
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - January 13, 2023 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Overexpression of BCL2, BCL6, VEGFR1 and TWIST1 in Circulating Tumor Cells Derived from Patients with DLBCL Decreases Event-Free Survival
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - December 30, 2022 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Clinical Impact of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Associated Clostridioides difficile Infection Among Patients with Lung Cancer
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - December 28, 2022 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Combination Use of First-Line Afatinib and Proton-Pump Inhibitors Reduces Overall Survival Among Patients with EGFFR Mutant Lung Cancer
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - December 28, 2022 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Spotlight on Targeted Chemotherapy in Retinoblastoma: Safety, Efficacy, and Patient Outcomes
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - December 21, 2022 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Response to Article “Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages” [Response to Letter]
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - December 21, 2022 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Targeted Therapy for Locally Advanced or Metastatic Urothelial Cancer (mUC): Therapeutic Potential of Sacituzumab Govitecan
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - December 21, 2022 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Targeted Treatment of Locally Advanced and Metastatic Urothelial Cancer: Enfortumab Vedotin in Context
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - December 15, 2022 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Targeting RAD51-Mediated Homologous Recombination as a Treatment for Advanced Solid and Hematologic Malignancies: Opportunities and Challenges Ahead
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - December 13, 2022 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Silencing of Long Non-Coding RNA Colon Cancer-Associated Transcript 2 Inhibits the Growth and Metastasis of Gastric Cancer Through Blocking mTOR Signaling [Retraction]
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - December 9, 2022 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Circular RNA PVT1 Promotes the Invasion and Epithelial –Mesenchymal Transition of Breast Cancer Cells through Serving as a Competing Endogenous RNA for miR-204-5p [Retraction]
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - December 6, 2022 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Diffuse Large B-Cell Lymphoma (DLBCL): Early Patient Management and Emerging Treatment Options
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - December 5, 2022 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
